Maxcyte (MXCT) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Maxcyte (MXCT) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.91% |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.36% |
| Mar 31, 2026 | -460.58% |
| Dec 31, 2025 | 28.24% |
| Sep 30, 2025 | -272.43% |
| Jun 30, 2025 | -1,218.18% |
| Mar 31, 2025 | 91.44% |
| Dec 31, 2024 | 53.96% |
| Sep 30, 2024 | 71.68% |
| Jun 30, 2024 | 93.87% |
| Mar 31, 2024 | 25.59% |
| Dec 31, 2023 | -80.23% |
| Sep 30, 2023 | -490.23% |
| Jun 30, 2023 | -45.95% |
| Mar 31, 2023 | -4,326.73% |
| Sep 30, 2022 | 98.79% |
| Jun 30, 2022 | 77.40% |
| Mar 31, 2022 | 99.99% |
| Sep 30, 2021 | -278.51% |
| Jun 30, 2021 | -25.92% |